JP2004534739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004534739A5 JP2004534739A5 JP2002574948A JP2002574948A JP2004534739A5 JP 2004534739 A5 JP2004534739 A5 JP 2004534739A5 JP 2002574948 A JP2002574948 A JP 2002574948A JP 2002574948 A JP2002574948 A JP 2002574948A JP 2004534739 A5 JP2004534739 A5 JP 2004534739A5
- Authority
- JP
- Japan
- Prior art keywords
- water
- soluble
- composition
- polymer
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims 14
- 239000000203 mixture Substances 0.000 claims 13
- 239000004480 active ingredient Substances 0.000 claims 11
- 239000003945 anionic surfactant Substances 0.000 claims 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 7
- 239000003093 cationic surfactant Substances 0.000 claims 6
- 230000002378 acidificating effect Effects 0.000 claims 5
- 239000008247 solid mixture Substances 0.000 claims 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000000129 anionic group Chemical group 0.000 claims 2
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 239000007909 solid dosage form Substances 0.000 claims 2
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 claims 2
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 claims 2
- 229920003169 water-soluble polymer Polymers 0.000 claims 2
- 108010039918 Polylysine Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 229920006187 aquazol Polymers 0.000 claims 1
- 239000012861 aquazol Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims 1
- 150000007524 organic acids Chemical group 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 229920002401 polyacrylamide Polymers 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- -1 polyvinylamine Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10114869 | 2001-03-26 | ||
| DE2001117049 DE10117049A1 (de) | 2001-04-05 | 2001-04-05 | Zusammensetzung |
| PCT/EP2002/003387 WO2002076432A2 (en) | 2001-03-26 | 2002-03-26 | Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004534739A JP2004534739A (ja) | 2004-11-18 |
| JP2004534739A5 true JP2004534739A5 (https=) | 2005-06-09 |
| JP4330343B2 JP4330343B2 (ja) | 2009-09-16 |
Family
ID=26008913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002574948A Expired - Lifetime JP4330343B2 (ja) | 2001-03-26 | 2002-03-26 | 低水溶性活性成分、界面活性剤および水溶性ポリマーを含んでなる医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20040077232A1 (https=) |
| EP (1) | EP1372611B1 (https=) |
| JP (1) | JP4330343B2 (https=) |
| CN (1) | CN100350911C (https=) |
| AT (1) | ATE326216T1 (https=) |
| AU (1) | AU2002304784A1 (https=) |
| BR (1) | BR0208306A (https=) |
| CA (1) | CA2439097C (https=) |
| CY (1) | CY1106159T1 (https=) |
| DE (1) | DE60211494T2 (https=) |
| DK (1) | DK1372611T3 (https=) |
| ES (1) | ES2261671T3 (https=) |
| PT (1) | PT1372611E (https=) |
| WO (1) | WO2002076432A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003208245A1 (en) * | 2002-03-15 | 2003-09-29 | Kuyus, Stiftung | Composition and utilization thereof for forming a protective film on nasal mucous membranes |
| MX2007002415A (es) * | 2004-08-31 | 2007-04-23 | Novartis Ag | Uso de midostaurina para el tratamiento de tumores estromales gastrointestinales. |
| JO2897B1 (en) | 2004-11-05 | 2015-09-15 | نوفارتيس ايه جي | Organic compounds |
| RU2454220C2 (ru) | 2006-08-16 | 2012-06-27 | Новартис Аг | Способ получения твердых дисперсий высококристаллических терапевтических соединений |
| JP5161528B2 (ja) * | 2007-10-02 | 2013-03-13 | 浜松ホトニクス株式会社 | パクリタキセル微粒子、パクリタキセル微粒子分散液、および、これらの製造方法 |
| JP5149585B2 (ja) * | 2007-10-02 | 2013-02-20 | 浜松ホトニクス株式会社 | 微粒子分散液製造方法 |
| US20090087460A1 (en) * | 2007-10-02 | 2009-04-02 | Hamamatsu Photonics K.K. | Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these |
| WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| WO2011000811A2 (en) * | 2009-06-30 | 2011-01-06 | Novartis Ag | Organic compounds |
| EP2745853B1 (en) * | 2011-08-17 | 2023-03-15 | Toray Industries, Inc. | Medical device, and method for producing same |
| US10478498B2 (en) | 2014-06-20 | 2019-11-19 | Reform Biologics, Llc | Excipient compounds for biopolymer formulations |
| ES2910528T3 (es) * | 2014-12-02 | 2022-05-12 | Minerva Neurosciences Inc | Composiciones que comprenden 2-((1-(2(4-fluorofenil)-2-oxoetil)piperidin-4-il)metil)isoindolin-1-ona para tratar la esquizofrenia |
| KR20170084736A (ko) * | 2016-01-12 | 2017-07-21 | 삼성디스플레이 주식회사 | 표시장치 |
| WO2018013673A1 (en) * | 2016-07-13 | 2018-01-18 | Reform Biologics, Llc | Stabilizing excipients for therapeutic protein formulations |
| US11642199B2 (en) * | 2018-09-24 | 2023-05-09 | 3M Innovative Properties Company | Dental appliance with cosmetic therapeutic aqueous solution |
| CN113797163B (zh) * | 2020-06-17 | 2023-07-14 | 成都瑞沐生物医药科技有限公司 | 一种滴眼给药防治干性黄斑病变和视网膜光损伤的眼用制剂 |
| CN120641106A (zh) * | 2022-12-19 | 2025-09-12 | 深圳市药欣生物科技有限公司 | 局部药物组合物和其用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3754082A (en) * | 1970-06-11 | 1973-08-21 | Richardson Merrell Inc | Process and composition for botfly larvae eliminination |
| CA1141663A (en) * | 1979-09-06 | 1983-02-22 | Yukihisa Ishii | Ophthalmic solution for intraocular pressure adjustment |
| JPS61194034A (ja) * | 1985-02-25 | 1986-08-28 | Teijin Ltd | 経鼻投与用粉末状組成物 |
| JPS632932A (ja) * | 1986-06-23 | 1988-01-07 | Teijin Ltd | 経鼻投与用粉末状組成物 |
| US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
| US5213738A (en) * | 1990-05-15 | 1993-05-25 | L. Perrigo Company | Method for making a capsule-shaped tablet |
| IT1245761B (it) * | 1991-01-30 | 1994-10-14 | Alfa Wassermann Spa | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
| GB9325395D0 (en) * | 1993-12-11 | 1994-02-16 | Ciba Geigy Ag | Compositions |
| AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
| EP0733358A3 (de) * | 1995-03-21 | 1998-05-20 | Novartis AG | Intravenös applizierbare Nanosuspensionen |
| CA2291735A1 (en) * | 1997-05-27 | 1998-12-03 | Takahiro Ogawa | Israpafant-containing water-base preparations |
| TW546151B (en) * | 1997-07-23 | 2003-08-11 | Senju Pharma Co | Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
| DE19813661A1 (de) * | 1997-08-01 | 1999-02-04 | Solvay Pharm Gmbh | Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron |
| GB9903547D0 (en) * | 1999-02-16 | 1999-04-07 | Novartis Ag | Organic compounds |
| US6190869B1 (en) * | 1999-10-26 | 2001-02-20 | Isis Pharmaceuticals, Inc. | Antisense inhibition of protein kinase C-theta expression |
-
2002
- 2002-03-26 EP EP02732526A patent/EP1372611B1/en not_active Expired - Lifetime
- 2002-03-26 AU AU2002304784A patent/AU2002304784A1/en not_active Abandoned
- 2002-03-26 WO PCT/EP2002/003387 patent/WO2002076432A2/en not_active Ceased
- 2002-03-26 DK DK02732526T patent/DK1372611T3/da active
- 2002-03-26 US US10/469,757 patent/US20040077232A1/en not_active Abandoned
- 2002-03-26 ES ES02732526T patent/ES2261671T3/es not_active Expired - Lifetime
- 2002-03-26 JP JP2002574948A patent/JP4330343B2/ja not_active Expired - Lifetime
- 2002-03-26 AT AT02732526T patent/ATE326216T1/de active
- 2002-03-26 DE DE60211494T patent/DE60211494T2/de not_active Expired - Lifetime
- 2002-03-26 CA CA2439097A patent/CA2439097C/en not_active Expired - Fee Related
- 2002-03-26 CN CNB028073460A patent/CN100350911C/zh not_active Expired - Lifetime
- 2002-03-26 PT PT02732526T patent/PT1372611E/pt unknown
- 2002-03-26 BR BR0208306-0A patent/BR0208306A/pt active Search and Examination
-
2006
- 2006-08-03 CY CY20061101092T patent/CY1106159T1/el unknown
-
2008
- 2008-06-26 US US12/147,129 patent/US20080287417A1/en not_active Abandoned
-
2013
- 2013-09-12 US US14/025,219 patent/US20140018346A1/en not_active Abandoned
-
2014
- 2014-06-19 US US14/309,209 patent/US20140303145A1/en not_active Abandoned
-
2016
- 2016-06-20 US US15/186,736 patent/US20160287707A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004534739A5 (https=) | ||
| AU2004202702B2 (en) | Compositions comprising sympathomimetic amine salts unsuitable for illegal use | |
| US20080287417A1 (en) | Pharmaceutical compositions comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer | |
| US20040208931A1 (en) | Fast dissolving films for oral administration of drugs | |
| US20070122475A1 (en) | Taste masking composition | |
| CY1110264T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν ευαισθητα σε ρη συμπολυμερη τυπου μπλοκ και υδροφοβο φαρμακο | |
| JPH11509223A5 (https=) | ||
| CA2401910A1 (en) | Hydrophilic molecular disperse solutions of carvedilol | |
| JP2009527505A5 (https=) | ||
| JPH1129497A5 (https=) | ||
| JP2004501964A5 (https=) | ||
| JP2007509902A5 (https=) | ||
| CN105188849A (zh) | 包含左乙拉西坦的快速分散剂型 | |
| JP2002521468A5 (https=) | ||
| CN1444473A (zh) | 在治疗真菌病时应用于口腔的组合物和剂型 | |
| JP2008538751A5 (https=) | ||
| JP2002509154A5 (https=) | ||
| WO1997018245A1 (en) | Complex of naproxen and beta-cyclodextrin | |
| US20080119519A1 (en) | Base Forming Drug-Layered Silicate Hybrid Containing Basic Polymer and its Synthesis Method | |
| RU2006133543A (ru) | Фармацевтическая композиция для орального применения и способ ее приготовления | |
| JP2002537246A5 (https=) | ||
| JP2007522223A5 (https=) | ||
| JP5500162B2 (ja) | 点眼剤 | |
| WO2005023236A1 (en) | Phenylephrine tannate, pyrilamine tannate, and dextromethorphan tannate salts in pharmaceutical compositions | |
| KR101739818B1 (ko) | 레바프라잔 또는 그의 염을 함유하는 현탁액 형태의 경구투여용 약학 조성물 |